IMMUNE THROMBOCYTOPENIA
Clinical trials for IMMUNE THROMBOCYTOPENIA explained in plain language.
Never miss a new study
Get alerted when new IMMUNE THROMBOCYTOPENIA trials appear
Sign up with your email to follow new studies for IMMUNE THROMBOCYTOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug tested to boost platelets in japanese blood disorder patients
Disease control CompletedThis study tested whether a drug called avatrombopag is safe and effective at raising platelet counts in Japanese adults with chronic immune thrombocytopenia (ITP), a condition where the immune system attacks platelets. Nineteen participants took the drug for 26 weeks. The main g…
Matched conditions: IMMUNE THROMBOCYTOPENIA
Phase: PHASE3 • Sponsor: Sobi, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New pill tested to help patients with low platelets avoid dangerous bleeding
Disease control CompletedThis study tested a daily pill called lusutrombopag in Chinese adults with persistent or chronic immune thrombocytopenia (ITP), a condition where the immune system attacks platelets, increasing bleeding risk. The goal was to see if the drug could safely raise and maintain platele…
Matched conditions: IMMUNE THROMBOCYTOPENIA
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for kids with rare bleeding disorder
Disease control CompletedThis study tested whether a medicine called avatrombopag could safely and effectively raise platelet counts in children with long-term immune thrombocytopenia (ITP), a condition that causes low platelets and increased bleeding risk. 75 children participated, receiving either the …
Matched conditions: IMMUNE THROMBOCYTOPENIA
Phase: PHASE3 • Sponsor: Sobi, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New pill shows promise for stubborn blood disorder
Disease control CompletedThis study tested a new oral medication called PRN1008 (rilzabrutinib) for adults with immune thrombocytopenia (ITP), a condition causing dangerously low platelet counts. It involved about 86 people whose previous treatments had stopped working or didn't help enough. The main goa…
Matched conditions: IMMUNE THROMBOCYTOPENIA
Phase: PHASE2 • Sponsor: Principia Biopharma, a Sanofi Company • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC
-
Doctors track rare blood disorders to find better treatment paths
Knowledge-focused CompletedThis study created a registry to track children and young adults with severe immune blood disorders like immune thrombocytopenia and autoimmune hemolytic anemia. Researchers observed 80 participants over up to 4 years to better understand these conditions and document how patient…
Matched conditions: IMMUNE THROMBOCYTOPENIA
Sponsor: Medical University of Graz • Aim: Knowledge-focused
Last updated Apr 04, 2026 00:35 UTC
-
Could treating cancer also cure a blood disorder?
Knowledge-focused CompletedThis study aimed to understand why some people with cancer also develop a condition called immune thrombocytopenia (ITP), which causes dangerously low platelet counts and bleeding risk. Researchers analyzed medical records from 33 adults who had both ITP and cancer to see if trea…
Matched conditions: IMMUNE THROMBOCYTOPENIA
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:58 UTC